![]() |
市場調查報告書
商品編碼
1871528
2021-2031年歐洲奈米顆粒測量儀器市場報告:範圍、細分、動態和競爭分析Europe Nanoparticle Measurement Instrument Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
||||||
歐洲奈米顆粒測量儀器市場預計將大幅成長,到 2031 年將達到約 27.6303 億美元,高於 2023 年的 18.9758 億美元,反映出 2023 年至 2031 年的年複合成長率(CAGR) 為 4.8%。
執行摘要和市場分析
歐洲奈米顆粒測量儀器市場主要分為幾個區域,包括德國、法國、義大利、英國、西班牙以及歐洲其他地區。歐洲奈米顆粒測量儀器市場的成長主要得益於這些儀器在疾病建模、基因突變研究和腫瘤建模等領域的日益廣泛應用,以及相關研究活動的增加。此外,公共和私營部門加大資金投入預計將在未來幾年為市場擴張創造更多機會。
市場區隔
歐洲奈米顆粒測量儀器市場可按類型和最終用戶進行分類。
按類型分類:市場涵蓋多種儀器,例如X光衍射儀、掃描電子顯微鏡、原子力顯微鏡、光子相關光譜儀、奈米顆粒表面積監測儀、透射電子顯微鏡、冷凝粒子計數器、差分遷移率分析儀、掃描遷移率粒徑譜儀、奈米顆粒追蹤分析儀、氣溶膠粒子質量分析儀等。值得注意的是,透射電子顯微鏡在2023年佔據了最大的市場。
按最終用戶分類:市場可細分為生物技術行業、製藥行業、合約研究組織 (CRO) 和其他行業。 2023 年,製藥業在市場佔有率方面領先。
市場展望
利用奈米技術開發藥物遞送系統的研究正在迅速發展。奈米技術能夠實現藥物的標靶和定點遞送,進而提高慢性疾病的治療效果。目前,人們正在探索各種奈米藥物在化療和免疫療法中的應用。近期的研究重點在於利用奈米材料的獨特性能來改進藥物遞送系統,以解決生物利用度低和吸收不佳等難題。例如,阿斯特捷利康公司正在研究脂質奈米顆粒(LNP),將其作為基於核苷酸療法的創新遞送系統,該療法能夠在目標細胞內生成治療性蛋白質。 Creative Biolabs公司也致力於該領域的研究,其先進的活性藥物成分(API)製劑開發系統提供聚合物奈米顆粒、脂質體和奈米晶體等技術。預計未來基於奈米技術的藥物遞送系統的持續進步將為奈米顆粒測量儀器市場創造巨大的發展機會。
國家概況
按國家/地區分類的市場分析顯示,德國在2023年佔據最大市場佔有率。值得關注的事件包括定於2024年9月在柏林舉行的第三屆歐洲脂質奈米顆粒開發高峰會,屆時將匯聚脂質奈米顆粒開發領域的關鍵參與者,包括葛蘭素史克、強生和CureVac等大型企業。本次高峰將探討脂質奈米顆粒開發的關鍵挑戰,例如脂質表徵和標靶遞送,為奈米醫學領域的知識交流和創新提供平台,這將使德國的市場參與者受益。
2023 年 12 月,來自漢堡歐洲分子生物學實驗室 (EMBL)、美因茨約翰內斯·古騰堡大學、Postnova Analytics GmbH 和 BioNTech SE 的研究人員推出了一種新的分析方法,該方法將非對稱流場流動分級 (AF4) 與小角 X光散射 (SAXS) 相結合,尤其是藥物負載物的複合物尺寸,尤其大小。
此外,Spectradyne公司宣布其nCS1儀器在德國的安裝量顯著成長,該儀器目前已被用於分析外泌體和測量液體潔淨度,充分展現了其多功能性和精確性。奈米技術研發投入的成長、對創新奈米顆粒藥物遞送系統日益成長的需求,以及市場參與者推出的先進技術,都是推動德國奈米顆粒測量儀器市場成長的關鍵因素。
公司簡介
奈米顆粒測量儀器市場的主要參與者包括布魯克、Spectradyne LLC、馬爾文帕納科有限公司、IZON Science LTD、Particle Metrix GmbH、Microtrac Retsch GmbH、堀場有限公司、Angstrom Advanced Inc.、島津公司和橫河電機株式會社。這些公司正在採用各種策略,例如市場擴張、產品創新以及併購,以增強其產品和服務並提高市場佔有率。
The Europe nanoparticle measurement instrument market is projected to grow significantly, reaching approximately USD 2,763.03 million by 2031, up from USD 1,897.58 million in 2023, reflecting a compound annual growth rate (CAGR) of 4.8% from 2023 to 2031.
Executive Summary and Market Analysis
The market is divided into several key regions, including Germany, France, Italy, the UK, Spain, and the Rest of Europe. The growth of the nanoparticle measurement instruments market in Europe is driven by the increasing use of these instruments in disease modeling, gene mutation research, and tumor modeling, alongside a rise in research activities. Additionally, enhanced funding and investments from both public and private sectors are expected to create further opportunities for market expansion in the coming years.
Market Segmentation
The Europe nanoparticle measurement instrument market can be categorized based on type and end user.
By Type: The market includes various instruments such as X-Ray diffractometers, scanning electron microscopes, atomic force microscopes, photon correlation spectroscopy devices, nanoparticle surface area monitors, transmission electron microscopes, condensation particle counters, differential mobility analyzers, scanning mobility particle sizers, nanoparticle tracking analyzers, aerosol particle mass analyzers, and others. Notably, the transmission electron microscope held the largest market share in 2023.
By End User: The market is segmented into the biotechnology sector, pharmaceutical industry, contract research organizations (CROs), and others. The pharmaceutical industry was the leading segment in terms of market share in 2023.
Market Outlook
Research in drug delivery systems utilizing nanotechnology is rapidly advancing. Nanotechnology enhances the effectiveness of treatments for chronic diseases by enabling targeted and site-specific delivery of medications. Various nanomedicine agents are being explored for applications in chemotherapy and immunotherapy. Recent developments focus on improving drug delivery systems through the unique properties of nanomaterials, addressing challenges such as poor bioavailability and suboptimal absorption. For example, lipid nanoparticles (LNPs) are being investigated by AstraZeneca as innovative delivery systems for nucleotide-based therapies that generate therapeutic proteins within target cells. Creative Biolabs is also contributing to this field with advanced formulation development systems for active pharmaceutical ingredients (APIs), offering technologies for polymeric nanoparticles, liposomes, and nanocrystals. Continuous advancements in nanotechnology-based drug delivery systems are anticipated to create substantial opportunities for the nanoparticle measurement instrument market in the future.
Country Insights
The market analysis by country reveals that Germany held the largest share in 2023. Noteworthy events, such as the 3rd Lipid Nanoparticles Development Summit Europe scheduled for September 2024 in Berlin, will gather key players in lipid nanoparticle development, including major companies like GSK, Johnson & Johnson, and CureVac. This summit will address critical challenges in LNP development, such as lipid characterization and targeted delivery, providing a platform for knowledge exchange and innovation in nanomedicine, which could benefit market players in Germany.
In December 2023, researchers from the European Molecular Biology Laboratory (EMBL) Hamburg, Johannes Gutenberg University Mainz, Postnova Analytics GmbH, and BioNTech SE introduced a new analytical method combining asymmetrical-flow field-flow fractionation (AF4) with small-angle X-ray scattering (SAXS) to accurately assess the size, structure, and RNA payload of nanoparticles in pharmaceutical products, particularly focusing on lipoplex formulations.
Additionally, Spectradyne announced a significant increase in the installation of its nCS1 instrument in Germany, which is now being utilized for analyzing exosomes and measuring fluid cleanliness, showcasing the instrument's versatility and precision. The growth of R&D initiatives in nanotechnology, the rising demand for innovative nanoparticle-based drug delivery systems, and the introduction of advanced technologies by market players are key factors propelling the growth of the nanoparticle measurement instrument market in Germany.
Company Profiles
Key players in the nanoparticle measurement instrument market include Bruker, Spectradyne LLC, Malvern Panalytical Ltd, IZON Science LTD, Particle Metrix GmbH, Microtrac Retsch GmbH, Horiba Ltd, Angstrom Advanced Inc., Shimadzu Corp, and Yokogawa Electric Corp. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.